tiprankstipranks
Recursion Pharmaceuticals (NASDAQ:RXRX) AI-Driven Drug Discovery Offers Promising Upside
PremiumMarket NewsRecursion Pharmaceuticals (NASDAQ:RXRX) AI-Driven Drug Discovery Offers Promising Upside
12d ago
Recursion Pharmaceuticals appoints Khan as Chief R&D Officer, CCO
PremiumThe Fly
Recursion Pharmaceuticals appoints Khan as Chief R&D Officer, CCO
20d ago
Recursion Pharmaceuticals Welcomes New Director and C-Suite Executive
PremiumCompany Announcements
Recursion Pharmaceuticals Welcomes New Director and C-Suite Executive
20d ago
Recursion Pharmaceuticals call volume above normal and directionally bullish
PremiumThe FlyRecursion Pharmaceuticals call volume above normal and directionally bullish
2M ago
Unusually active option classes on open March 14th
PremiumThe Fly
Unusually active option classes on open March 14th
2M ago
Recursion Pharmaceuticals call volume above normal and directionally bullish
PremiumThe Fly
Recursion Pharmaceuticals call volume above normal and directionally bullish
2M ago
Recursion to Participate in Upcoming Investor Conferences
PremiumPress ReleasesRecursion to Participate in Upcoming Investor Conferences
2M ago
Recursion Pharmaceuticals reports Q4 EPS (42c), consensus (45c)
PremiumThe Fly
Recursion Pharmaceuticals reports Q4 EPS (42c), consensus (45c)
2M ago
Recursion Pharmaceuticals Enhances Investor Communication Strategy
PremiumCompany Announcements
Recursion Pharmaceuticals Enhances Investor Communication Strategy
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100